Definium Therapeutics, Inc. (DFTX)
23.45
+1.05
(+4.69%)
USD |
NASDAQ |
May 06, 16:00
23.38
-0.07
(-0.30%)
After-Hours: 20:00
Definium Therapeutics EPS Diluted (Quarterly) : -0.5106 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Atai Beckley, Inc. | -1.734 |
| Plus Therapeutics, Inc. | -1.03 |
| Viridian Therapeutics, Inc. | 0.00 |
| Nutriband, Inc. | -0.0796 |
| Immunovant, Inc. | -0.6095 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.44M |
| Total Expenses (Quarterly) | 50.44M |
| Enterprise Value | 1.862B |
| Earnings Yield | -8.82% |
| Normalized Earnings Yield | -8.055 |